Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis

Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS

(2012) I. I. Kirov et al.   NEUROLOGY

Doubly selective multiple quantum chemical shift imaging andT1relaxation time measurement of glutathione (GSH) in the human brainin vivo

(2012) In-Young Choi et al.   NMR IN BIOMEDICINE

Magnetic Resonance Techniques in Multiple Sclerosis

(2011) Massimo Filippi   ARCHIVES OF NEUROLOGY

Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T

(2010) I-Y Choi et al.   Multiple Sclerosis Journal

Combined 1H and 31P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis

(2010) Elke Hattingen et al.   NMR IN BIOMEDICINE

Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 Tesla

(2010) Fahmy Aboul-Enein et al.   PLoS One

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

Prognosis of the individual course of disease: the elements of time, hetereogeneity and precision

(2009) Martin Daumer et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis

(2009) Radhika Srinivasan et al.   MAGNETIC RESONANCE IMAGING

MRI in multiple sclerosis: current status and future prospects

(2008) Rohit Bakshi et al.   LANCET NEUROLOGY

Historical and Clinical Perspectives of the Expanded Disability Status Scale

(2008) John F. Kurtzke   NEUROEPIDEMIOLOGY